Advances in Pharmacy Practice

Philadelphia College of Pharmacy is pleased to present the 39th Annual Symposium on Advances in Pharmacy Practice, a continuing pharmacy educational program, developed for pharmacists to be kept up to date on pharmacy practice. Daniel A. Hussar, PhD, will present New Drugs of 2017.

Daniel Ventricelli, PharmD, MPH and George Downs, PharmD will present Going Beyond Red Flags: Identifying and Addressing Opioid Use Disorder and Addiction. Jill Rebuck, PharmD, MBA will present Pharmacy Clinical Pearls.

The introduction of new drugs into the marketplace is one of the most important topics for pharmacists. It is equally important to understand current patient safety and pharmacy law issues affecting pharmacy practice. 

Faculty

Daniel A. Hussar, PhD
Remington Professor of Pharmacy
Philadelphia College of Pharmacy
USciences

Daniel Ventricelli, PharmD, MPH
Assistant Professor of Clinical Pharmacy
USciences

George Downs, PharmD
Dean Emeritus, Philadelphia College of Pharmacy
Professor of Clinical Pharmacy
USciences

Jill Rebuck, PharmD, MBA
Director of Pharmacy
Milton S. Hershey Medical Center

Dates and Locations

Sunday March 11, 2018

Milton S. Hershey Medical Center
University Conference Center
500 University Drive, Room 302A
Hershey, PA 17003
Directions

Sunday, April 15, 2018

USciences Campus
McNeil Science and Technology Center
45th Street at Woodland Avenue
Philadelphia, PA 19104
Directions

Learning Objectives

After attending this program, pharmacists will be able to:

New Drugs of 2017

  • Identify the indications, routes of administration, important pharmacokinetic properties, and unique characteristics of the new therapeutic agents marketed in 2017.
  • Identify the most common adverse effects of new therapeutic agents marketed in 2017.
  • Compare the newer products to similar medications already on the market.

Pharmacy Clinical Pearls

  • Compare and contrast the atypical side effects and risks associated with proton pump inhibitor administration.
  • Discuss best possible dosing strategies for low molecular weight heparins in special patient populations.
  • Describe optimization opportunities for completing the “best possible medication history” for a complex patient with multiple recent hospitalizations.

Going Beyond Red Flags: Identifying and Addressing Opioid Use Disorder and Addiction

  • Summarize the epidemiology of opioid use and misuse across the United States and Pennsylvania.
  • Discuss diagnostic criteria for Opioid Use Disorder (OUD) and relevant patient risk factors.
  • Describe non-medication and medication related factors

Agenda

7:30–8:00 a.m. Registration and Breakfast
8:00–9:00 a.m. Pharmacy Clinical Pearls
Jill Rebuck, PharmD, MBA
(0056-9999-18-001-L04-P)
9:00–11:00 a.m. New Drugs of 2017
Daniel A. Hussar, PhD
(0056-9999-17-068-L01-P)
11:00–11:15 a.m. Break
11:15 a.m.–1:15 p.m. Going Beyond Red Flags: Identifying and Addressing Opioid Use Disorder and Addiction
Daniel Ventricelli, PharmD, MPH
George Downs, PharmD
(0056-9999-18-002-L01-P)

Cost and Registration

Advanced registration is encouraged as seating may be limited. The registration fee is $95.00 for 5 CE hours.

Register Online

If you must cancel after registering, USciences will refund your fee if notice of your cancellation is received at least five business days prior to the program. No refunds will be given if notice of cancellation is received after this time.

Please check this website for cancellations or delays due to inclement weather or for additional updates.

acpe logoContinuing Education Credit

Philadelphia College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

UAN:

0056-9999-18-001-L04-P (0.1 CEUs)

0056-9999-17-068-L01-P (0.2 CEUs)

0056-9999-18-002-L01-P (0.2 CEUs)

Target Audience: These knowledge-based activities have been developed for pharmacists.

To obtain credit: For successful completion of the program and eligibility for credit, the participant must be present for the entire program to receive a program “claiming code”. In order to obtain credit for this program, please log into the PCP CECENTER website
https://www.highmarksce.com/pcp/ to register and complete the online program evaluation and learning assessment exam. A score of 70% or higher, with a maximum of 3 attempts, is required to claim credit. Submission of learning assessments and program evaluations must be completed within 30 days of the program expiration date to receive continuing education credit. Please note that it may take up to 4 weeks for credits to be processed and available on CPE Monitor.

Licensure Reminder

Pennsylvania pharmacists are required to complete 2 hours of continuing education on Patient Safety.

More Information

For more information, call 215-596-7619 or email usciencesevents@usciences.edu.

This program has not received any financial support.

Address:

University of the Sciences
600 South 43rd Street
Philadelphia, PA 19104-4495

Phone:

215-596-7619

Email:

usciencesevents@usciences.edu